High-intensity Interval Circuit Training in People With Parkinson Disease (PD HIIT)

Comparison of High-intensity Interval Circuit Training With Upper Extremity and Lower Extremity Training Versus Lower Extremity Training Alone in People With Parkinson Disease

The goal of the study is to compare different types of high intensity circuit exercises over an 8-class training series in people with Parkinson disease. The main question it aims to answer is:

-Does including arm and hand exercises with leg exercises improve reaction time, balance, functional measures, gait speed and quality of life? This group will be compared to a group that only does leg exercises. Participants will be asked to participate in 8 high intensity circuit exercise classes.

Study Overview

Detailed Description

People with Parkinson disease will be recruited from the community and randomized into 2 equal groups: high intensity interval circuit training with lower extremity (LE) and lower and upper extremity (LEUE) training. The study will be composed of a baseline assessment, 8 group class sessions, and a post-intervention assessment. The baseline assessment will include demographics, disease and fall history and outcome measure collection. Group class sessions will include concurrent group warmup, followed by an 8-station circuit performed with high intensity intervals, and a cool-down. The circuit will include 4 stations performed by both the LE and LEUE groups and 4 stations specific to each intervention group, including 4 additional LE exercise stations for the LE group and 4 UE specific stations for the LEUE group. The stations that differ will not be adjacent to one another nor specifically indicated as different. The stations that differ will mirror similar aspects of function (ie, strength, reaction time, etc.) for the UE and LE stations. Participants will be told exercise stations may vary within-session and week to week but will not be informed that only one group has UE exercise interventions. After conclusion of the class series, post-intervention balance and stepping outcomes will be reassessed.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Yakima, Washington, United States, 98901
        • Pacific Northwest University of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosis of Parkinson's disease
  • Hoehn and Yahr level of 1 to 3
  • ability to walk independently with or without an assistive device
  • obtain medical clearance to participate in moderate or vigorous exercise.

Exclusion Criteria:

  • diagnosis of any neurological disease other than PD (including but not limited to stroke, dementia, and multiple sclerosis; mild cognitive impairment is not excluded)
  • bone instability (non-consolidated fractures, unstable spinal column, severe osteoporosis)
  • muscle or ligament tears
  • uncontrolled hypertension
  • uncontrolled diabetes
  • severe cardiovascular disease that impairs walking or exercise
  • a major change in medication during the study training period (pre-test to post-test)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lower extremity and upper extremity exercise
Exercises in the circuit (8 total) will focus on the lower extremity (4) and upper extremity (4)
Exercises performed at high intensity effort in the circuit (8 total) will focus on both the lower extremity (4) and upper extremity (4)
Active Comparator: Lower extremity exercise
Exercises in the circuit (8 total) will focus on the lower extremity (4) alone.
All exercises performed at high intensity effort in the circuit (8 total) will focus on the lower extremity alone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trail making Test Parts A and B (timed, higher scores mean worse outcome)
Time Frame: 8-10 weeks
Cognitive and fine motor skills
8-10 weeks
Activity-specific Balance Confidence Scale (0-100%, higher scores mean better outcome)
Time Frame: 8-10 weeks
Balance confidence self-report
8-10 weeks
Timed Up and Go
Time Frame: 8-10 weeks
Balance and function
8-10 weeks
10 meter Walk Test
Time Frame: 8-10 weeks
Gait Speed
8-10 weeks
6 minute walk test
Time Frame: 8-10 weeks
endurance
8-10 weeks
9-hole peg test (timed, higher scores mean worse outcome)
Time Frame: 8-10 weeks
fine motor
8-10 weeks
Parkinson's Disease Questionnaire - Short Form (8) (Score 0-32, higher scores mean worse outcome)
Time Frame: 8-10 weeks
Quality of Life
8-10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tiffany B Salido, DPT, PhD, Pacific Northwest University of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2024

Primary Completion (Actual)

November 30, 2025

Study Completion (Actual)

November 30, 2025

Study Registration Dates

First Submitted

July 12, 2024

First Submitted That Met QC Criteria

August 26, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on High intensity circuit exercise class - Lower and upper extremity

Subscribe